Dow Down 0.04% Nasdaq Down 0.13%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.22 Down 0.03(0.59%) 10:06AM EDT - Nasdaq Real Time Price
Prev Close:4.25
Open:4.25
Bid:4.21 x 6400
Ask:4.22 x 5000
1y Target Est:7.06
Beta:-2.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.20 - 4.26
52wk Range:4.05 - 7.97
Volume:302,524
Avg Vol (3m):4,928,020
Market Cap:928.80M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 0.59%928.80M
GSKUp 0.73%116.76B
OREXUp 0.17%722.95M
RHHBYDown 0.08%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback